Asia’s First Pre-Clinical Network Facility Inaugurated in Faridabad

July 20, 2024

Asia’s first Pre-clinical Network Facility for health study was opened in Faridabad, Haryana by Dr. Jitendra Singh, Minister of State for Science and Technology. This building is part of the Coalition for Epidemic Preparedness Innovations (CEPI), and its goal is to make studies better in case of an epidemic.

What is CEPI?

CEPI, or the Coalition for Epidemic Preparedness Innovations, is a global group whose goal is to speed up the creation of vaccines for infectious diseases. By letting people work together on study and funding, CEPI wants to help people get ready for and deal with epidemics.

Role of BRIC-THSTI

Because it can handle Biosafety Level 3 (BSL3) pathogens, CEPI has named the BRIC-Translational Health Science and Technology Institute (THSTI) as a pre-clinical network laboratory. With this high-tech lab, medicines and treatments can be fully tested and improved.

Significance of the Pre-clinical Network Facility

It’s the first building of its kind in Asia and the ninth in the world overall. Setting it up improves India’s ability to plan for epidemics and makes it easier for researchers from around the world to work together, which helps deal with urgent health threats more effectively.

Experimental Animal Facility

This building has one of the biggest living areas for small animals in India. It can hold about 75,000 mice and other animals. This is an important resource for pre-clinical studies because it provides a controlled setting for trying drugs and vaccines.

About Coalition of Epidemic Preparedness Innovations (CEPI)

In 2017, the Coalition for Epidemic Preparedness Innovations (CEPI) was formed to speed up the process of making vaccines. Its main focus is on new contagious diseases that could spread quickly, like Ebola and Lassa fever. CEPI is a partnership between the government, non-governmental organizations (NGOs), and the business sector. The goal is to make sure that everyone has equal access to vaccines during breakouts. CEPI has spent more than $1 billion on research and development for vaccines. It works with the World Health Organization (WHO) and groups such as GAVI and the Global Fund for TB, AIDS, and Malaria.

« Previous Post Next Post »